Neurofibromatosis Type 1–Associated MPNST State of the Science: Outlining a Research Agenda for the Future

@inproceedings{Ossemane2017NeurofibromatosisT1,
  title={Neurofibromatosis Type 1–Associated MPNST State of the Science: Outlining a Research Agenda for the Future},
  author={Ezequiel B. Ossemane and Troy D. Moon and Martin C. Were and Elizabeth Heitman},
  booktitle={JAMIA},
  year={2017}
}
Objectives No estimates exist regarding the extent of prescription opioid use among US adults who are the primary caregivers to children. Methods Data were from Wave IV of the National Longitudinal Study of Adolescent to Adult Health. Respondents were age 24 to 32 years. We compared the prevalence of prescription opioid use in the last four weeks and medical conditions with the potential to precipitate use among parents (i.e., one or more children living in the household) and nonparents. We… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
0 Extracted Citations
23 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 23 references

Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant C O M M EN T A R Y 5 of 6 | JNCI

  • M Miettinen, CR Antonescu, CD Fletcher
  • J Natl Cancer Inst, 2017,
  • 2017
Highly Influential
7 Excerpts

SARC016: Phase II study of everolimus in combination with bevacizumab in sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST)

  • BC Widemann, CF Meyer, GM Cote
  • J Clin Oncol
  • 2016

Similar Papers

Loading similar papers…